Alec Machiels is Director of Apellis Pharmaceuticals, Inc.. Currently has a direct ownership of 370,761 shares of APLS, which is worth approximately $12.1 Million. The most recent transaction as insider was on Nov 16, 2020, when has been sold 2,500 shares (Common Stock) at a price of $39.38 per share, resulting in proceeds of $98,450. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 371K
0% 3M change
0.91% 12M change
Total Value Held $12.1 Million

Alec Machiels Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 16 2020
SELL
Open market or private sale
$98,450 $39.38 p/Share
2,500 Reduced 0.37%
669,544 Common Stock
Nov 16 2020
BUY
Exercise of conversion of derivative security
$6,675 $2.67 p/Share
2,500 Added 0.37%
672,044 Common Stock
Oct 15 2020
SELL
Open market or private sale
$87,500 $35.0 p/Share
2,500 Reduced 0.37%
669,544 Common Stock
Oct 15 2020
BUY
Exercise of conversion of derivative security
$6,675 $2.67 p/Share
2,500 Added 0.37%
672,044 Common Stock
Oct 07 2020
SELL
Open market or private sale
$262,500 $35.0 p/Share
7,500 Reduced 1.11%
669,544 Common Stock
Oct 07 2020
BUY
Exercise of conversion of derivative security
$20,025 $2.67 p/Share
7,500 Added 1.1%
677,044 Common Stock
AM

Alec Machiels

Director
Waltham, MA

Track Institutional and Insider Activities on APLS

Follow Apellis Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells APLS shares.

Notify only if

Insider Trading

Get notified when an Apellis Pharmaceuticals, Inc. insider buys or sells APLS shares.

Notify only if

News

Receive news related to Apellis Pharmaceuticals, Inc.

Track Activities on APLS